HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Risperidone as monotherapy for a patient with obsessive compulsive disorder comorbid with schizoaffective disorder: a case report.

Abstract
Data on the efficacy of antipsychotics as monotherapy for obsessive-compulsive disorder (OCD) are inadequate. This report presents the case of a patient with OCD that was successfully treated with risperidone as monotherapy. Assessments revealed significant reductions in OCD symptoms after risperidone treatment (4 mg/d). This report suggests the beneficial effect of risperidone for a patient with OCD comorbid with schizoaffective disorder.
AuthorsYu-Jie Chiou, Pao-Yen Lin, Yu Lee
JournalClinical neuropharmacology (Clin Neuropharmacol) 2015 May-Jun Vol. 38 Issue 3 Pg. 114-6 ISSN: 1537-162X [Electronic] United States
PMID25970281 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antipsychotic Agents
  • Serotonin Antagonists
  • Risperidone
Topics
  • Adult
  • Antipsychotic Agents (therapeutic use)
  • Comorbidity
  • Humans
  • Male
  • Obsessive-Compulsive Disorder (drug therapy, psychology)
  • Psychotic Disorders (drug therapy, psychology)
  • Risperidone (administration & dosage, therapeutic use)
  • Serotonin Antagonists (therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: